cyclocreatine has been researched along with creatine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 12 (52.17) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Griffiths, GR; Walker, JB | 1 |
| Chase, PB; Kushmerick, MJ; Moerland, TS; Stuppard, R; Wiseman, RW | 1 |
| Cohn, M; Ito, K; Ivanics, T; Jahngen, EG; Osbakken, M; Ponomarenko, I; Zhang, D | 1 |
| Allam, ME; Cordis, GA; Elgebaly, SA; Farghaly, A; Forouhar, F; Kreutzer, DL; Rossomando, EF | 1 |
| Bhat, AM; Carlier, PG; Gerken, TA; Jacobstein, MD | 1 |
| Cohn, M; LoPresti, P | 1 |
| Roberts, JJ; Walker, JB | 1 |
| Kushmerick, MJ; Wiseman, RW | 1 |
| Ivanics, T; Osbakken, MD; Wehrli, S; Wroblewski, K; Zhang, D | 1 |
| Cohn, M; Evans, AE; Miller, EE | 1 |
| Bergnes, G; Kaddurah-Daouk, R; Khandekar, VS; Martin, KJ; O'Keefe, MM; Teicher, BA; Yuan, W | 1 |
| Beal, MF; Ferrante, RJ; Jenkins, BG; Kaddurah-Daouk, R; Matthews, RT; Rosen, BR; Yang, L | 1 |
| Clair, T; Khaddurah-Daouk, R; Liotta, LA; Mulvaney, PT; Nam, SW; O'Keefe, M; Schiffmann, E; Stracke, ML; Woodhouse, E | 1 |
| Askenasy, N; Jain, RK; Koretsky, AP; Kristensen, CA | 1 |
| Beal, MF; Ferrante, RJ; Kaddurah-Daouk, R; Klein, AM; Klivenyi, P; Matthews, RT; Mueller, G; Yang, L | 1 |
| Cohn, M; Degani, H; Maril, N; Rushkin, E; Sherry, AD | 1 |
| Diehl, V; Kornacker, B; Kornacker, M; Negrin, RS; Schlattner, U; Staratschek-Jox, A; Verneris, MR; Wallimann, T; Wolf, J | 1 |
| Dolder, M; Schlattner, U; Speer, O; Wallimann, T; Walzel, B | 1 |
| Abu Rialy, S; Farhat, F; Francis, E; Geha, G; Kurdit, RM; Lteif, L; Maraashli, W; Mikati, MA; Rahmeh, AA | 1 |
| Class, B; Do, MT; Fisher, E; Frigeni, M; Gorshkov, K; Huang, W; Longo, N; Ottinger, EA; Singleton, M; Sun, W; Thorne, N; Wang, AQ; Xu, X; Zheng, W | 1 |
| Alessandrì, MG; Baroncelli, L; Battini, R; Butt, M; Cacciante, F; Cerri, E; Cioni, G; Do, MT; Gennaro, M; Lupori, L; Mazziotti, R; McKew, JC; Pizzorusso, T; Putignano, E; Sagona, G | 1 |
| Butt, M; Cavagnaro, J; Do, MT; McKew, JC; Terse, PS | 1 |
| Fleming, J; Ford, CA; Leung, HY; Lynch, V; Mackay, G; Mui, E; Patel, R; Rodgers, L; Rushworth, LK; Sansom, OJ; Sumpton, D; Vande Voorde, J; Watson, D; Zhang, T | 1 |
23 other study(ies) available for cyclocreatine and creatine
| Article | Year |
|---|---|
Accumulation of analgo of phosphocreatine in muscle of chicks fed 1-carboxymethyl-2-iminoimidazolidine (cyclocreatine).
Topics: Animals; Chickens; Creatine; Creatine Kinase; Creatinine; Diet; Imidazolidines; Kinetics; Muscles; Phosphocreatine; Spectrophotometry | 1976 |
High-performance liquid chromatographic assays for free and phosphorylated derivatives of the creatine analogues beta-guanidopropionic acid and 1-carboxy-methyl-2-iminoimidazolidine (cyclocreatine).
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Creatine; Creatinine; Guanidines; Male; Mice; Muscles; Propionates | 1992 |
Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
Topics: Adenosine Triphosphate; Animals; Creatine; Creatinine; Diet; Female; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion Injury; Myocardium; Perfusion; Phosphates; Phosphocreatine; Rats; Rats, Inbred Strains | 1992 |
Cyclocreatine inhibits the production of neutrophil chemotactic factors from isolated hearts.
Topics: Adenosine Triphosphate; Animals; Chemotactic Factors; Chemotaxis, Leukocyte; Creatine; Creatinine; Heart; In Vitro Techniques; Kinetics; Neutrophils; Perfusion; Rabbits | 1990 |
Myocardial protection during ischemia by prior feeding with the creatine analog: cyclocreatine.
Topics: Adenosine Triphosphate; Administration, Oral; Animals; Creatine; Creatinine; Energy Metabolism; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Myocardium; Phosphates; Rats; Rats, Inbred Strains | 1989 |
Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Creatine; Creatine Kinase; Creatinine; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy | 1989 |
Feeding a creatine analogue delays ATP depletion and onset of rigor in ischemic heart.
Topics: Adenosine Triphosphate; Animals; Coronary Disease; Creatine; Creatinine; Heart; Kinetics; Male; Myocardial Contraction; Myocardium; Phosphates; Rats; Rats, Inbred Strains | 1982 |
Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Creatine; Creatine Kinase; Creatinine; Guanidines; Magnetic Resonance Spectroscopy; Male; Mice; Models, Chemical; Muscle, Skeletal; Phosphocreatine; Phosphorus Isotopes; Propionates; Solutions; Thermodynamics | 1995 |
31P relaxation rates to evaluate physiological events in the heart.
Topics: Adenosine Triphosphate; Animals; Catalase; Creatine; Creatinine; Diet; Female; Heart; Magnetic Resonance Spectroscopy; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 1993 |
Inhibition of rate of tumor growth by creatine and cyclocreatine.
Topics: Animals; Antineoplastic Agents; Cell Division; Creatine; Creatinine; Diet; Female; Humans; Kinetics; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neuroblastoma; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors; Transplantation, Heterologous | 1993 |
Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Death; Colonic Neoplasms; Creatine; Creatine Kinase; Creatinine; Female; Humans; Neoplasms, Experimental; Phosphocreatine; Rats; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1996 |
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Antineoplastic Agents; Creatine; Creatinine; Disease Models, Animal; Energy Metabolism; Free Radicals; Huntington Disease; Lactates; Male; Malonates; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley; Tyrosine | 1998 |
Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase.
Topics: Antineoplastic Agents; Cell Movement; Chemotaxis; Cisplatin; Creatine; Creatine Kinase; Creatinine; Humans; Male; Melanoma; Neoplasm Invasiveness; Prostatic Neoplasms; Tumor Cells, Cultured | 1998 |
Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Water; Cell Division; Colonic Neoplasms; Creatine; Creatine Kinase; Creatinine; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Nude; Phosphorus; Phosphorylation; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Administration, Oral; Animals; Creatine; Creatinine; Dopamine; Dopamine Agents; Immunohistochemistry; Male; Mice; MPTP Poisoning; Neurons; Neuroprotective Agents; Nissl Bodies; Substantia Nigra; Tyrosine 3-Monooxygenase | 1999 |
Kinetics of cyclocreatine and Na(+) cotransport in human breast cancer cells: mechanism of activity.
Topics: Biological Transport; Breast Neoplasms; Cell Division; Creatine; Creatine Kinase; Creatinine; Female; Humans; Intracellular Membranes; Kinetics; Magnetic Resonance Spectroscopy; Phosphorus; Sodium; Tumor Cells, Cultured | 1999 |
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Death; Cell Division; Creatine; Creatine Kinase; Creatinine; Dose-Response Relationship, Drug; Gene Expression Profiling; Hodgkin Disease; Humans; Hydrogen-Ion Concentration; Immunoblotting; Mitochondria; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Tumor Cells, Cultured | 2001 |
Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.
Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Cell Survival; Chromatography, Thin Layer; Creatine; Creatine Kinase; Creatinine; Dose-Response Relationship, Drug; Guanidines; Ion Channels; Liver; Magnesium; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Biological; Neurodegenerative Diseases; Oxygen; Oxygen Consumption; Phosphocreatine; Phosphorylation; Propionates; Protein Binding; Time Factors | 2003 |
Effects of creatine and cyclocreatine supplementation on kainate induced injury in pre-pubescent rats.
Topics: Acute Disease; Aggression; Animals; Anticonvulsants; Creatine; Creatinine; Dietary Supplements; Emotions; Hippocampus; Kainic Acid; Learning Disabilities; Male; Neuroprotective Agents; Phenobarbital; Rats; Rats, Sprague-Dawley; Recurrence; Seizures; Status Epilepticus | 2004 |
Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.
Topics: Brain Diseases, Metabolic, Inborn; Cells, Cultured; Chromatography, High Pressure Liquid; Creatine; Creatinine; Fibroblasts; Humans; Imidazolidines; Mental Retardation, X-Linked; Phosphocreatine; Plasma Membrane Neurotransmitter Transport Proteins; Primary Cell Culture; Tandem Mass Spectrometry | 2019 |
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Topics: Animals; Autistic Disorder; Blood-Brain Barrier; Brain Diseases, Metabolic, Inborn; Cerebrovascular Circulation; Cognition Disorders; Creatine; Creatinine; Disease Models, Animal; Electroencephalography; Epilepsy; Hemodynamics; Male; Mental Retardation, X-Linked; Mice; Mice, Inbred C57BL; Phenotype; Plasma Membrane Neurotransmitter Transport Proteins; Seizures; Stereotyped Behavior | 2020 |
Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
Topics: Animals; Antineoplastic Agents; Brain; Brain Diseases, Metabolic, Inborn; Creatine; Creatinine; Disease Models, Animal; Humans; Membrane Transport Proteins; Mental Retardation, X-Linked; Mice; No-Observed-Adverse-Effect Level; Plasma Membrane Neurotransmitter Transport Proteins; Seizures; Tissue Distribution | 2021 |
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Topics: Animals; Creatine; Creatinine; Disease Models, Animal; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Phosphocreatine; Prostatic Neoplasms | 2022 |